Non-Invasive Brain Stimulation for Traumatic Brain Injury
(SMART Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a gentle, non-invasive brain stimulation called TACS can enhance thinking and decision-making in individuals with mild to moderate traumatic brain injury (TBI). Participants will receive either the actual stimulation or a placebo treatment without stimulation. The trial seeks adults who have experienced a mild to moderate TBI and can comfortably use a computer for assessments. As an Early Phase 1 trial, this research focuses on understanding how TACS functions in people, offering participants the opportunity to explore this innovative treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
What prior data suggests that this non-invasive brain stimulation is safe for traumatic brain injury?
Research has shown that non-invasive brain stimulation methods, like the one being tested, hold promise for people with traumatic brain injuries (TBI). Current studies suggest these treatments are generally safe. Trials focused on TBI have found no major safety issues. In fact, results indicate that patients tolerate these techniques well. While more research is needed, existing evidence suggests this type of therapy has a good safety record.12345
Why are researchers excited about this trial's treatments?
Researchers are excited about non-invasive brain stimulation for traumatic brain injury (TBI) because it offers a novel approach compared to traditional treatments like medication and rehabilitation therapy. Unlike standard care, which often focuses on managing symptoms, this method uses external non-invasive techniques to stimulate brain activity directly. This approach has the potential to enhance brain recovery by promoting neural connections without the need for surgery or drugs. Additionally, it could offer faster improvements in cognitive function, providing new hope for TBI patients seeking effective and accessible recovery options.
What evidence suggests that this trial's treatments could be effective for traumatic brain injury?
Research has shown that non-invasive brain stimulation, such as transcutaneous alternating current stimulation (TACS), may enhance thinking skills in individuals with traumatic brain injury (TBI). Some studies suggest these methods can slightly improve abilities like memory and decision-making for TBI patients. A review of research also highlights positive effects of these brain stimulation techniques on brain disorders, including TBI. In this trial, participants will join either a stimulation group or a sham group. Although more research is needed, early findings suggest potential benefits from this treatment.12467
Who Is on the Research Team?
David Darrow, MD MPH
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had a mild to moderate traumatic brain injury (TBI) and can perform computerized tests. They must understand the consent process and commit to all appointments. It's not for those with severe TBI, scalp wounds, pacemakers/defibrillators, non-English speakers, or visual issues affecting computer use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcutaneous alternating current stimulation (tACS) or sham stimulation once weekly for six weeks to improve cognitive function and decision-making after traumatic brain injury
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- COGED
- External non-invasive stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
United States Department of Defense
Collaborator
Uniformed Services University of the Health Sciences
Collaborator